OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 9 results.
Search:

SKU Category Vector Description Price Delivery
SC302800 Human cDNA pCMV6-XL KCNIP1 (untagged)-Human Kv channel interacting protein 1 (KCNIP1), transcript variant 3 (10ug) NM_001034838.1 $380 2-3 weeks
RC224153 Human ORF PS100001 KCNIP1 (Myc-DDK-tagged)-Human Kv channel interacting protein 1 (KCNIP1), transcript variant 3 $380 2-3 weeks
RC224153L1 Human ORF PS100064 Lenti-ORF clone of KCNIP1 (Myc-DDK-tagged)-Human Kv channel interacting protein 1 (KCNIP1), transcript variant 3, (10ug) $750 4-5 weeks
RC224153L2 Human ORF PS100071 Lenti-ORF clone of KCNIP1 (mGFP-tagged)-Human Kv channel interacting protein 1 (KCNIP1), transcript variant 3, (10ug) $830 4-5 weeks
RG224153 Human ORF PS100010 KCNIP1 (GFP-tagged) - Human Kv channel interacting protein 1 (KCNIP1), transcript variant 3 $420 2-3 weeks
TF312015 Human shRNA pRFP-C-RS KCNIP1 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector $650 7-9 Days
TG312015 Human shRNA pGFP-V-RS KCNIP1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector $650 7-9 Days
TR312015 Human shRNA pRS KCNIP1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector $650 7-9 Days
/ UTR pMirTarget 3`UTR clone of Kv channel interacting protein 1 (KCNIP1) transcript variant 3 for miRNA target validation NM_001034838.1 $495 3-4 weeks
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title